Specialty biopharmaceutical company, Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) recently entered into a co-promotion agreement with GlaxoSmithKline plc‘s (NYSE:GSK) U.S. subsidiary, GlaxoSmithKline LLC. The companies signed an agreement for the co-promotion of Auxilium Pharma’s Testim (1% testosterone), which is approved for the treatment of hypogonadism or low testosterone level.
Deal Terms
The deal provides Glaxo with exclusive rights to co-promote Testim in the U.S. with Auxilium Pharma … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards